中國衛生(00673.HK)斥1.53億元購滴眼劑分銷商51%股權
中國衛生集團(00673.HK)公佈,其全資附屬隆恆投資以代價1.53億元,向Double Bliss Investments、周旺及Alpha Success International收購目標公司Golden Alliance 51%股權。代價將通過發行總金額4,712.5萬元之承兌票據,及向賣方配售最多8,750萬股代價股份的方式支付,佔公司擴大後股本約16.62%,每股代價股份1.21元,較該股昨日(6日)收市價1.5元折讓約19.3%。
目標集團主要從事醫藥及相關產品之分銷及營銷,並由一支經驗豐富之管理團隊營運。目標集團已獲得希目明滴眼劑等產品於中國之長期獨家分銷權利,並已獲得供應該等產品之銷售協議,料完成後可帶來總收入約2.14億元人民幣。目標集團亦正計劃擴大其產品供應及分銷渠道,以實現強勁且可持續增長。
公司認爲,收購事項將令其進一步拓闊其醫療分銷業務之覆蓋範圍,並使其產品組合從醫療器械多元化至藥品。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.